Range
3.66 - 3.79
Vol / Avg.
35.9K/130.3K
Div / Yield
-
52 Wk
3.14 - 6.84
Mkt Cap
198.7M
Payout Ratio
-
Open
3.72
P/E
-
EPS
-0.11
Shares
53.6M
Outstanding
53.6M
Total Float
-
load more
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors.

Related Companies

TickerCompanyChg %Mkt Cap
MDNAMedicenna Therapeutics0.27%198.7M

Medicenna Therapeutics Frequently Asked Questions

Q

How do I buy Medicenna Therapeutics (MDNA) stock?

A

You can purchase shares of Medicenna Therapeutics (NASDAQ: MDNA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Medicenna Therapeutics's (MDNA) competitors?

A

There are no as such competitors for Medicenna Therapeutics.

Q

What is the target price for Medicenna Therapeutics (MDNA) stock?

A

There is no analysis for Medicenna Therapeutics

Q

Current Stock Price for Medicenna Therapeutics (MDNA)?

A

The stock price for Medicenna Therapeutics (NASDAQ: MDNA) is $3.71 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Medicenna Therapeutics (MDNA) pay a dividend?

A

There are no upcoming dividends for Medicenna Therapeutics.

Q

When is Medicenna Therapeutics (NASDAQ:MDNA) reporting earnings?

A

Medicenna Therapeutics does not have any upcoming earnings scheduled.

Q

Is Medicenna Therapeutics (MDNA) going to split?

A

There is no upcoming split for Medicenna Therapeutics.

Q

What sector and industry does Medicenna Therapeutics (MDNA) operate in?

A

Medicenna Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.